1
|
Morgan D, Reid CM, Guiry PJ. Enantioselective Copper-Catalyzed Alkynylation of Quinolones Using Chiral P,N Ligands. J Org Chem 2024; 89:1993-2000. [PMID: 37967026 PMCID: PMC10845117 DOI: 10.1021/acs.joc.3c01944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2023] [Revised: 10/26/2023] [Accepted: 11/01/2023] [Indexed: 11/17/2023]
Abstract
Herein we report a catalytic enantioselective alkynylation of quinolones. In this reaction, quinolones are silylated to form a quinolinium ion which then undergoes an enantioselective attack by a copper acetylide, templated by (S,S,Ra)-UCD-Phim. This gives alkynylated products (24 examples) in yields of up to 92% and enantioselectivities of up to 97%. This methodology has been applied to the synthesis of two natural products, (+)-cuspareine and (+)-galipinine.
Collapse
Affiliation(s)
- Dáiríne
M. Morgan
- Centre
for Synthesis and Chemical Biology,
Synthesis and Solid State Pharmaceutical Centre, School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland
| | - Cian M. Reid
- Centre
for Synthesis and Chemical Biology, School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland
| | - Patrick J. Guiry
- Centre
for Synthesis and Chemical Biology,
Synthesis and Solid State Pharmaceutical Centre, School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland
| |
Collapse
|
2
|
Biosca M, de la Cruz-Sánchez P, Faiges J, Margalef J, Salomó E, Riera A, Verdaguer X, Ferré J, Maseras F, Besora M, Pàmies O, Diéguez M. P-Stereogenic Ir-MaxPHOX: A Step toward Privileged Catalysts for Asymmetric Hydrogenation of Nonchelating Olefins. ACS Catal 2023; 13:3020-3035. [PMID: 36910869 PMCID: PMC9990153 DOI: 10.1021/acscatal.2c05579] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 01/17/2023] [Indexed: 02/16/2023]
Abstract
The Ir-MaxPHOX-type catalysts demonstrated high catalytic performance in the hydrogenation of a wide range of nonchelating olefins with different geometries, substitution patterns, and degrees of functionalization. These air-stable and readily available catalysts have been successfully applied in the asymmetric hydrogenation of di-, tri-, and tetrasubstituted olefins (ee's up to 99%). The combination of theoretical calculations and deuterium labeling experiments led to the uncovering of the factors responsible for the enantioselectivity observed in the reaction, allowing the rationalization of the most suitable substrates for these Ir-catalysts.
Collapse
Affiliation(s)
- Maria Biosca
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Pol de la Cruz-Sánchez
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Jorge Faiges
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Jèssica Margalef
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Ernest Salomó
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), C/Baldiri Reixac, 10, 08028 Barcelona, Spain
| | - Antoni Riera
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), C/Baldiri Reixac, 10, 08028 Barcelona, Spain.,Departament de Química Inorgànica i Orgànica, Secció Química Orgànica, Universitat de Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
| | - Xavier Verdaguer
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), C/Baldiri Reixac, 10, 08028 Barcelona, Spain.,Departament de Química Inorgànica i Orgànica, Secció Química Orgànica, Universitat de Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
| | - Joan Ferré
- Departament de Química Analítica i Química Orgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Feliu Maseras
- Institute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Avenida Països Catalans 16, 43007 Tarragona, Spain
| | - Maria Besora
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Oscar Pàmies
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Montserrat Diéguez
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| |
Collapse
|
3
|
Yin C, Pan Y, Zhang X, Yin Q. Catalytic Asymmetric Hydrogenation of Tetrasubstituted Unsaturated Lactams: An Efficient Approach to Enantioenriched 3,4-Disubstituted Piperidines. Org Lett 2022; 24:675-680. [PMID: 35005963 DOI: 10.1021/acs.orglett.1c04132] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Asymmetric hydrogenation of tetrasubstituted alkenes remains a formidable challenge in asymmetric catalysis. We report herein an unprecedented Rh-catalyzed enantioselective and diastereoselective hydrogenation of easily accessed α,β-disubstituted unsaturated lactams to afford synthetically valuable chiral lactams with 1,2-consecutive stereocenters. The reaction could be performed on the gram scale, and the products could be concisely transformed to enantiomerically pure trans-3,4-disubstituted piperidines, which are prevalent structural units in medicinal agents.
Collapse
Affiliation(s)
- Congcong Yin
- Guangdong Provincial Key Laboratory of Catalysis, Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China
| | - Yingmin Pan
- Guangdong Provincial Key Laboratory of Catalysis, Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China
| | - Xumu Zhang
- Guangdong Provincial Key Laboratory of Catalysis, Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China
| | - Qin Yin
- Shenzhen Institute of Advanced Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China
| |
Collapse
|
4
|
Kar S, Sanderson H, Roy K, Benfenati E, Leszczynski J. Green Chemistry in the Synthesis of Pharmaceuticals. Chem Rev 2021; 122:3637-3710. [PMID: 34910451 DOI: 10.1021/acs.chemrev.1c00631] [Citation(s) in RCA: 91] [Impact Index Per Article: 30.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The principles of green chemistry (GC) can be comprehensively implemented in green synthesis of pharmaceuticals by choosing no solvents or green solvents (preferably water), alternative reaction media, and consideration of one-pot synthesis, multicomponent reactions (MCRs), continuous processing, and process intensification approaches for atom economy and final waste reduction. The GC's execution in green synthesis can be performed using a holistic design of the active pharmaceutical ingredient's (API) life cycle, minimizing hazards and pollution, and capitalizing the resource efficiency in the synthesis technique. Thus, the presented review accounts for the comprehensive exploration of GC's principles and metrics, an appropriate implication of those ideas in each step of the reaction schemes, from raw material to an intermediate to the final product's synthesis, and the final execution of the synthesis into scalable industry-based production. For real-life examples, we have discussed the synthesis of a series of established generic pharmaceuticals, starting with the raw materials, and the intermediates of the corresponding pharmaceuticals. Researchers and industries have thoughtfully instigated a green synthesis process to control the atom economy and waste reduction to protect the environment. We have extensively discussed significant reactions relevant for green synthesis, one-pot cascade synthesis, MCRs, continuous processing, and process intensification, which may contribute to the future of green and sustainable synthesis of APIs.
Collapse
Affiliation(s)
- Supratik Kar
- Interdisciplinary Center for Nanotoxicity, Department of Chemistry, Physics and Atmospheric Sciences, Jackson State University, Jackson, Mississippi 39217, United States
| | - Hans Sanderson
- Department of Environmental Science, Section for Toxicology and Chemistry, Aarhus University, Frederiksborgvej 399, DK-4000 Roskilde, Denmark
| | - Kunal Roy
- Drug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.,Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 19, 20156 Milano, Italy
| | - Emilio Benfenati
- Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 19, 20156 Milano, Italy
| | - Jerzy Leszczynski
- Interdisciplinary Center for Nanotoxicity, Department of Chemistry, Physics and Atmospheric Sciences, Jackson State University, Jackson, Mississippi 39217, United States
| |
Collapse
|
5
|
Qu B, Wei X, Zeng X, Yang BS, Desrosiers JN, Savoie J, Wang J, Marsini MA, Li Z, Haddad N, Lorenz JC, Tielmann P, Maier N, Song JJ, Senanayake CH. Large-Scale Enantioselective Reduction of 2,3-Disubstituted Indenopyridine Enables a Practical Manufacturing Process for an 11β-HSD-1 Inhibitor. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.1c00290] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Bo Qu
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xudong Wei
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xingzhong Zeng
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Bing-Shiou Yang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jean-Nicolas Desrosiers
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jolaine Savoie
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jun Wang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Maurice A. Marsini
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Zhibin Li
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Nizar Haddad
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jon C. Lorenz
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Patrick Tielmann
- Global Department Process Development Chemicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim, Germany
| | - Nora Maier
- Global Department Process Development Chemicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim, Germany
| | - Jinhua J. Song
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Chris H. Senanayake
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| |
Collapse
|
6
|
Evolution in heterodonor P-N, P-S and P-O chiral ligands for preparing efficient catalysts for asymmetric catalysis. From design to applications. Coord Chem Rev 2021. [DOI: 10.1016/j.ccr.2021.214120] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
7
|
Wan F, Wang N, Zhu Y, Tang C, Claverie J, Tang W. Enantioselective hydrogenation of cyclic tetrasubstituted-olefinic dehydroamino acid derivatives. Chem Commun (Camb) 2021; 57:5546-5549. [PMID: 33969835 DOI: 10.1039/d1cc01277k] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
An efficient asymmetric hydrogenation of cyclic tetrasubstituted-olefinic dehydroamino acid derivatives has been achieved with a Rh-ArcPhos catalyst, affording a series of α-acylamino-β-alkyl tetrahydropyranones with two contiguous chiral centers in up to 96% ee and 1000 TON.
Collapse
Affiliation(s)
- Feng Wan
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Ling Ling Road, Shanghai 200032, China.
| | - Nan Wang
- School of Physical Science and Technology, ShanghaiTech University, Shanghai 200031, China
| | - Yuxin Zhu
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Ling Ling Road, Shanghai 200032, China.
| | - Chuyan Tang
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Ling Ling Road, Shanghai 200032, China.
| | - Jerome Claverie
- Department of Chemistry, University of Sherbrooke, 2500 Blvd de l'Universit, Sherbrooke, Qc J1K2R1, Canada.
| | - Wenjun Tang
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Ling Ling Road, Shanghai 200032, China. and School of Physical Science and Technology, ShanghaiTech University, Shanghai 200031, China and School of Chemistry and Material Sciences, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, 1 Sub-lane Xiangshan, Hangzhou 310024, China
| |
Collapse
|
8
|
Liu M, Tang T, Apolinar O, Matsuura R, Busacca CA, Qu B, Fandrick DR, Zatolochnaya OV, Senanayake CH, Song JJ, Engle KM. Atom-Economical Cross-Coupling of Internal and Terminal Alkynes to Access 1,3-Enynes. J Am Chem Soc 2021; 143:3881-3888. [PMID: 33683868 DOI: 10.1021/jacs.0c12565] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Selective carbon-carbon (C-C) bond formation in chemical synthesis generally requires prefunctionalized building blocks. However, the requisite prefunctionalization steps undermine the overall efficiency of synthetic sequences that rely on such reactions, which is particularly problematic in large-scale applications, such as in the commercial production of pharmaceuticals. Herein, we describe a selective and catalytic method for synthesizing 1,3-enynes without prefunctionalized building blocks. In this transformation several classes of unactivated internal acceptor alkynes can be coupled with terminal donor alkynes to deliver 1,3-enynes in a highly regio- and stereoselective manner. The scope of compatible acceptor alkynes includes propargyl alcohols, (homo)propargyl amine derivatives, and (homo)propargyl carboxamides. This method is facilitated by a tailored P,N-ligand that enables regioselective addition and suppresses secondary E/Z-isomerization of the product. The reaction is scalable and can operate effectively with as low as 0.5 mol % catalyst loading. The products are versatile intermediates that can participate in various downstream transformations. We also present preliminary mechanistic experiments that are consistent with a redox-neutral Pd(II) catalytic cycle.
Collapse
Affiliation(s)
- Mingyu Liu
- Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
| | - Tianhua Tang
- Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
| | - Omar Apolinar
- Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
| | - Rei Matsuura
- Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
| | - Carl A Busacca
- Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, United States
| | - Bo Qu
- Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, United States
| | - Daniel R Fandrick
- Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, United States
| | - Olga V Zatolochnaya
- Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, United States
| | - Chris H Senanayake
- Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, United States
| | - Jinhua J Song
- Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, United States
| | - Keary M Engle
- Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
| |
Collapse
|
9
|
Li J, Yu B, Lu Z. Chiral Imidazoline Ligands and Their Applications in
Metal‐Catalyzed
Asymmetric Synthesis
†. CHINESE J CHEM 2021. [DOI: 10.1002/cjoc.202000486] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Jiajing Li
- Department of Chemistry, Zhejiang University Hangzhou Zhejiang 310058 China
| | - Bing Yu
- College of Chemistry, Zhengzhou University Zhengzhou Henan 450001 China
| | - Zhan Lu
- Department of Chemistry, Zhejiang University Hangzhou Zhejiang 310058 China
- College of Chemistry, Zhengzhou University Zhengzhou Henan 450001 China
| |
Collapse
|
10
|
Asymmetric hydrogenation of unfunctionalized olefins or with poorly coordinative groups. ADVANCES IN CATALYSIS 2021. [DOI: 10.1016/bs.acat.2021.08.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
11
|
Cabré A, Riera A, Verdaguer X. P-Stereogenic Amino-Phosphines as Chiral Ligands: From Privileged Intermediates to Asymmetric Catalysis. Acc Chem Res 2020; 53:676-689. [PMID: 32105437 DOI: 10.1021/acs.accounts.9b00633] [Citation(s) in RCA: 46] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Among chiral phosphines, P-stereogenic phosphines provide unparalleled activity and selectivity and have thus emerged as "state-of-the-art" ligands for asymmetric hydrogenation and other industrially relevant processes. However, the synthesis of this type of ligand implies lengthy multistep sequences, which are a hurdle for many laboratories. There is a lack of methods for the rapid construction of P-stereogenic phosphine ligands. In this respect, P-stereogenic synthons that can be rapidly incorporated into a given ligand scaffold are highly desirable. Over the last 10 years, our group has unveiled that P-stereogenic aminophosphines can be rapidly assembled in a convenient fashion from the corresponding primary aminophosphine and/or the corresponding phosphinous acid.Using cis-1-amino-2-indanol as chiral auxiliary, we devised a multigram synthesis of tert-butylmethylaminophosphine borane and tert-butylmethylphosphinous acid borane, which are key intermediate synthons. Primary aminophosphine works as nucleophilic intermediates at nitrogen. From this synthon, aminodiphosphine (MaxPHOS) and secondary imino phosphoranes (SIP) ligands were synthesized. These ligands exhibit a tautomeric equilibrium between the PH and NH forms, and because of that, they do not undergo oxidation in air. NH/PH tautomerism does not jeopardize their configurational stability, and most importantly, in the presence of a metal source, the equilibrium is shifted toward the NH form, thus allowing coordination through phosphorus. Rh-MaxPHOS and Rh-SIP complexes have been used in asymmetric hydrogenation and [2 + 2 + 2] cycloaddition reactions with outstanding results. On the other hand, P-stereogenic phosphinous acid, upon activation, serves as an electrophilic reagent with amine nucleophiles, allowing SN2 reactions at phosphorus with complete inversion of configuration. This coupling technology exhibits a great potential because it allows the incorporation of the P*-phosphine fragment in numerous ligand structures, provided there is an amino group with which to react. In a mild and efficient process, phosphinous acid has been coupled to hydrazine to yield C2 diphosphines and to chiral benzoimidazole-amines to yield P-stereogenic benzoimidazole-phosphine ligands. The most powerful ligand system, however, arises from the condensation of three independent fragments: our phosphinous acid borane, an amino acid, and an amino alcohol, which yields a library of phosphino-oxazoline ligands named MaxPHOX. The corresponding Ir-MaxPHOX catalyst library was applied with excellent results in the asymmetric hydrogenation of α,β-unsaturated esters, 2-aryl allyl phthalimides, unfunctionalized tetrasubstituted alkenes, cyclic enamides, and N-aryl and N-methyl imines. It also has found application in asymmetric isomerization of alkenes.Overall, we developed key P-stereogenic building blocks that can be incorporated stereospecifically to ligand scaffolds and demonstrated that integration of the P*-aminophosphine fragment in a given catalytic system provides structural diversity that can be a critical contribution to obtaining optimal results and selectivity.
Collapse
Affiliation(s)
- Albert Cabré
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028 Barcelona, Spain
- Departament de Quı́mica Inorgànica i Orgànica, Secció Orgànica, Facultat de Quı́mica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain
| | - Antoni Riera
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028 Barcelona, Spain
- Departament de Quı́mica Inorgànica i Orgànica, Secció Orgànica, Facultat de Quı́mica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain
| | - Xavier Verdaguer
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028 Barcelona, Spain
- Departament de Quı́mica Inorgànica i Orgànica, Secció Orgànica, Facultat de Quı́mica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain
| |
Collapse
|
12
|
Bigler R, Mack KA, Shen J, Tosatti P, Han C, Bachmann S, Zhang H, Scalone M, Pfaltz A, Denmark SE, Hildbrand S, Gosselin F. Asymmetric Hydrogenation of Unfunctionalized Tetrasubstituted Acyclic Olefins. Angew Chem Int Ed Engl 2020; 59:2844-2849. [PMID: 31794118 DOI: 10.1002/anie.201912640] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Indexed: 12/31/2022]
Abstract
Asymmetric hydrogenation has evolved as one of the most powerful tools to construct stereocenters. However, the asymmetric hydrogenation of unfunctionalized tetrasubstituted acyclic olefins remains the pinnacle of asymmetric synthesis and an unsolved challenge. We report herein the discovery of an iridium catalyst for the first, generally applicable, highly enantio- and diastereoselective hydrogenation of such olefins and the mechanistic insights of the reaction. The power of this chemistry is demonstrated by the successful hydrogenation of a wide variety of electronically and sterically diverse olefins in excellent yield and high enantio- and diastereoselectivity.
Collapse
Affiliation(s)
- Raphael Bigler
- Pharmaceutical Division, Small Molecules Technical Development, Department of Process Chemistry and Catalysis, F. Hoffmann-La Roche Ltd, 4070, Basel, Switzerland
| | - Kyle A Mack
- Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
| | - Jeff Shen
- Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
| | - Paolo Tosatti
- Pharmaceutical Division, Small Molecules Technical Development, Department of Process Chemistry and Catalysis, F. Hoffmann-La Roche Ltd, 4070, Basel, Switzerland
| | - Chong Han
- Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
| | - Stephan Bachmann
- Pharmaceutical Division, Small Molecules Technical Development, Department of Process Chemistry and Catalysis, F. Hoffmann-La Roche Ltd, 4070, Basel, Switzerland
| | - Haiming Zhang
- Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
| | - Michelangelo Scalone
- Pharmaceutical Division, Small Molecules Technical Development, Department of Process Chemistry and Catalysis, F. Hoffmann-La Roche Ltd, 4070, Basel, Switzerland
| | - Andreas Pfaltz
- Department of Chemistry, University of Basel, 4056, Basel, Switzerland
| | - Scott E Denmark
- Roger Adams Laboratory, Department of Chemistry, University of Illinois, Urbana, IL, 61801, USA
| | - Stefan Hildbrand
- Pharmaceutical Division, Small Molecules Technical Development, Department of Process Chemistry and Catalysis, F. Hoffmann-La Roche Ltd, 4070, Basel, Switzerland
| | - Francis Gosselin
- Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
| |
Collapse
|
13
|
Bigler R, Mack KA, Shen J, Tosatti P, Han C, Bachmann S, Zhang H, Scalone M, Pfaltz A, Denmark SE, Hildbrand S, Gosselin F. Asymmetric Hydrogenation of Unfunctionalized Tetrasubstituted Acyclic Olefins. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.201912640] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Raphael Bigler
- Pharmaceutical DivisionSmall Molecules Technical DevelopmentDepartment of Process Chemistry and CatalysisF. Hoffmann-La Roche Ltd 4070 Basel Switzerland
| | - Kyle A. Mack
- Department of Small Molecule Process ChemistryGenentech, Inc. 1 DNA Way South San Francisco CA 94080 USA
| | - Jeff Shen
- Department of Small Molecule Process ChemistryGenentech, Inc. 1 DNA Way South San Francisco CA 94080 USA
| | - Paolo Tosatti
- Pharmaceutical DivisionSmall Molecules Technical DevelopmentDepartment of Process Chemistry and CatalysisF. Hoffmann-La Roche Ltd 4070 Basel Switzerland
| | - Chong Han
- Department of Small Molecule Process ChemistryGenentech, Inc. 1 DNA Way South San Francisco CA 94080 USA
| | - Stephan Bachmann
- Pharmaceutical DivisionSmall Molecules Technical DevelopmentDepartment of Process Chemistry and CatalysisF. Hoffmann-La Roche Ltd 4070 Basel Switzerland
| | - Haiming Zhang
- Department of Small Molecule Process ChemistryGenentech, Inc. 1 DNA Way South San Francisco CA 94080 USA
| | - Michelangelo Scalone
- Pharmaceutical DivisionSmall Molecules Technical DevelopmentDepartment of Process Chemistry and CatalysisF. Hoffmann-La Roche Ltd 4070 Basel Switzerland
| | - Andreas Pfaltz
- Department of ChemistryUniversity of Basel 4056 Basel Switzerland
| | - Scott E. Denmark
- Roger Adams LaboratoryDepartment of ChemistryUniversity of Illinois Urbana IL 61801 USA
| | - Stefan Hildbrand
- Pharmaceutical DivisionSmall Molecules Technical DevelopmentDepartment of Process Chemistry and CatalysisF. Hoffmann-La Roche Ltd 4070 Basel Switzerland
| | - Francis Gosselin
- Department of Small Molecule Process ChemistryGenentech, Inc. 1 DNA Way South San Francisco CA 94080 USA
| |
Collapse
|
14
|
Iridium-Catalyzed Asymmetric Hydrogenation. TOP ORGANOMETAL CHEM 2020. [DOI: 10.1007/3418_2020_64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
Biosca M, Pàmies O, Diéguez M. Ir–Biaryl phosphite–oxazoline catalyst libraries: a breakthrough in the asymmetric hydrogenation of challenging olefins. Catal Sci Technol 2020. [DOI: 10.1039/c9cy02501d] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
This work describes our progress in the successful development of phosphite/phosphinite–oxazoline ligands for the Ir-catalyzed asymmetric hydrogenation of challenging olefins.
Collapse
Affiliation(s)
- Maria Biosca
- Universitat Rovira i Virgili
- Departament de Química Física i Inorgànica
- 1. 43007 Tarragona
- Spain
| | - Oscar Pàmies
- Universitat Rovira i Virgili
- Departament de Química Física i Inorgànica
- 1. 43007 Tarragona
- Spain
| | - Montserrat Diéguez
- Universitat Rovira i Virgili
- Departament de Química Física i Inorgànica
- 1. 43007 Tarragona
- Spain
| |
Collapse
|
16
|
Kerdphon S, Ponra S, Yang J, Wu H, Eriksson L, Andersson PG. Diastereo- and Enantioselective Synthesis of Structurally Diverse Succinate, Butyrolactone, and Trifluoromethyl Derivatives by Iridium-Catalyzed Hydrogenation of Tetrasubstituted Olefins. ACS Catal 2019. [DOI: 10.1021/acscatal.9b01508] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Sutthichat Kerdphon
- Department of Organic Chemistry, Stockholm University, Arrhenius Laboratory, Stockholm 10691, Sweden
| | - Sudipta Ponra
- Department of Organic Chemistry, Stockholm University, Arrhenius Laboratory, Stockholm 10691, Sweden
| | - Jianping Yang
- Department of Organic Chemistry, Stockholm University, Arrhenius Laboratory, Stockholm 10691, Sweden
| | - Haibo Wu
- Department of Organic Chemistry, Stockholm University, Arrhenius Laboratory, Stockholm 10691, Sweden
| | - Lars Eriksson
- Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius väg16C, Stockholm SE-10691, Sweden
| | - Pher G. Andersson
- Department of Organic Chemistry, Stockholm University, Arrhenius Laboratory, Stockholm 10691, Sweden
- School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4041, South Africa
| |
Collapse
|
17
|
Biosca M, Salomó E, de la Cruz-Sánchez P, Riera A, Verdaguer X, Pàmies O, Diéguez M. Extending the Substrate Scope in the Hydrogenation of Unfunctionalized Tetrasubstituted Olefins with Ir-P Stereogenic Aminophosphine–Oxazoline Catalysts. Org Lett 2019; 21:807-811. [DOI: 10.1021/acs.orglett.8b04084] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Maria Biosca
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Ernest Salomó
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), C/Baldiri Reixac, 10, 08028 Barcelona, Spain
| | - Pol de la Cruz-Sánchez
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Antoni Riera
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), C/Baldiri Reixac, 10, 08028 Barcelona, Spain
- Departament Química Inorgànica i Orgànica, Secció Orgànica, Universitat de Barcelona, C/Martí i Franquès, 1, 08028 Barcelona, Spain
| | - Xavier Verdaguer
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), C/Baldiri Reixac, 10, 08028 Barcelona, Spain
- Departament Química Inorgànica i Orgànica, Secció Orgànica, Universitat de Barcelona, C/Martí i Franquès, 1, 08028 Barcelona, Spain
| | - Oscar Pàmies
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| | - Montserrat Diéguez
- Departament de Química Física i Inorgànica, Universitat Rovira i Virgili, C/Marcel·lí Domingo, 1, 43007 Tarragona, Spain
| |
Collapse
|
18
|
Seo CSG, Morris RH. Catalytic Homogeneous Asymmetric Hydrogenation: Successes and Opportunities. Organometallics 2018. [DOI: 10.1021/acs.organomet.8b00774] [Citation(s) in RCA: 135] [Impact Index Per Article: 22.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Chris S. G. Seo
- Department of Chemistry, University of Toronto, M5S3H6 Toronto, Ontario, Canada
| | - Robert H. Morris
- Department of Chemistry, University of Toronto, M5S3H6 Toronto, Ontario, Canada
| |
Collapse
|
19
|
Biosca M, Magre M, Pàmies O, Diéguez M. Asymmetric Hydrogenation of Disubstituted, Trisubstituted, and Tetrasubstituted Minimally Functionalized Olefins and Cyclic β-Enamides with Easily Accessible Ir–P,Oxazoline Catalysts. ACS Catal 2018. [DOI: 10.1021/acscatal.8b03170] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Maria Biosca
- Universitat Rovira i Virgili. Departament de Química Física i Inorgànica. C/Marcel·lí Domingo 1, 43007 Tarragona, Spain
| | - Marc Magre
- Universitat Rovira i Virgili. Departament de Química Física i Inorgànica. C/Marcel·lí Domingo 1, 43007 Tarragona, Spain
| | - Oscar Pàmies
- Universitat Rovira i Virgili. Departament de Química Física i Inorgànica. C/Marcel·lí Domingo 1, 43007 Tarragona, Spain
| | - Montserrat Diéguez
- Universitat Rovira i Virgili. Departament de Química Física i Inorgànica. C/Marcel·lí Domingo 1, 43007 Tarragona, Spain
| |
Collapse
|
20
|
Kraft S, Ryan K, Kargbo RB. Recent Advances in Asymmetric Hydrogenation of Tetrasubstituted Olefins. J Am Chem Soc 2017; 139:11630-11641. [DOI: 10.1021/jacs.7b07188] [Citation(s) in RCA: 110] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Stefan Kraft
- Drug Discovery Services,
Medicinal Chemistry, Albany Molecular Research Inc., 26 Corporate Circle, Albany, New York 12201-5098, United States
| | - Kristen Ryan
- Drug Discovery Services,
Medicinal Chemistry, Albany Molecular Research Inc., 26 Corporate Circle, Albany, New York 12201-5098, United States
| | - Robert B. Kargbo
- Drug Discovery Services,
Medicinal Chemistry, Albany Molecular Research Inc., 26 Corporate Circle, Albany, New York 12201-5098, United States
| |
Collapse
|
21
|
Margarita C, Andersson PG. Evolution and Prospects of the Asymmetric Hydrogenation of Unfunctionalized Olefins. J Am Chem Soc 2017; 139:1346-1356. [DOI: 10.1021/jacs.6b10690] [Citation(s) in RCA: 125] [Impact Index Per Article: 17.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Cristiana Margarita
- Department of Organic Chemistry, Stockholm University, S-10691 Stockholm, Sweden
| | - Pher G. Andersson
- Department of Organic Chemistry, Stockholm University, S-10691 Stockholm, Sweden
| |
Collapse
|
22
|
Zanotti-Gerosa A, Gazić Smilović I, Časar Z. Acid promoted Ir–P^N complex catalyzed hydrogenation of heavily hindered 3,4-diphenyl-1,2-dihydronaphthalenes: asymmetric synthesis of lasofoxifene tartrate. Org Chem Front 2017. [DOI: 10.1039/c7qo00525c] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
An asymmetric hydrogenation of minimally functionalized tetrasubstituted cyclic olefins has been developed using an Ir–P^N catalyst and an acid additive enabling the synthesis of lasofoxifene tartrate.
Collapse
Affiliation(s)
| | - Ivana Gazić Smilović
- Lek Pharmaceuticals
- d.d
- Sandoz Development Center Slovenia
- SI-1526 Ljubljana
- Slovenia
| | - Zdenko Časar
- Lek Pharmaceuticals
- d.d
- Sandoz Development Center Slovenia
- SI-1526 Ljubljana
- Slovenia
| |
Collapse
|
23
|
Zhang Z, Butt NA, Zhang W. Asymmetric Hydrogenation of Nonaromatic Cyclic Substrates. Chem Rev 2016; 116:14769-14827. [DOI: 10.1021/acs.chemrev.6b00564] [Citation(s) in RCA: 224] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Zhenfeng Zhang
- School of Pharmacy and ‡School of Chemistry and Chemical
Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China
| | - Nicholas A. Butt
- School of Pharmacy and ‡School of Chemistry and Chemical
Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China
| | - Wanbin Zhang
- School of Pharmacy and ‡School of Chemistry and Chemical
Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China
| |
Collapse
|
24
|
Wei X, Qu B, Zeng X, Savoie J, Fandrick KR, Desrosiers JN, Tcyrulnikov S, Marsini MA, Buono FG, Li Z, Yang BS, Tang W, Haddad N, Gutierrez O, Wang J, Lee H, Ma S, Campbell S, Lorenz JC, Eckhardt M, Himmelsbach F, Peters S, Patel ND, Tan Z, Yee NK, Song JJ, Roschangar F, Kozlowski MC, Senanayake CH. Sequential C-H Arylation and Enantioselective Hydrogenation Enables Ideal Asymmetric Entry to the Indenopiperidine Core of an 11β-HSD-1 Inhibitor. J Am Chem Soc 2016; 138:15473-15481. [PMID: 27794616 DOI: 10.1021/jacs.6b09764] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A concise asymmetric synthesis of an 11β-HSD-1 inhibitor has been achieved using inexpensive starting materials with excellent step-economy at low catalyst loadings. The catalytic enantioselective total synthesis of 1 was accomplished in 7 steps and 38% overall yield aided by the development of an innovative, sequential strategy involving Pd-catalyzed pyridinium C-H arylation and Ir-catalyzed asymmetric hydrogenation of the resulting fused tricyclic indenopyridinium salt highlighted by the use of a unique P,N-ligand (MeO-BoQPhos) with 1000 ppm of [Ir(COD)Cl]2.
Collapse
Affiliation(s)
- Xudong Wei
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Bo Qu
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xingzhong Zeng
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jolaine Savoie
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Keith R Fandrick
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jean-Nicolas Desrosiers
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Sergei Tcyrulnikov
- Department of Chemistry, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States
| | - Maurice A Marsini
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Frederic G Buono
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Zhibin Li
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Bing-Shiou Yang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Wenjun Tang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Nizar Haddad
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Osvaldo Gutierrez
- Department of Chemistry, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States
| | - Jun Wang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Heewon Lee
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Shengli Ma
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Scot Campbell
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jon C Lorenz
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Matthias Eckhardt
- Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG , Birkendorfer Strasse 65, 88397 Biberach/Riss, Germany
| | - Frank Himmelsbach
- Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG , Birkendorfer Strasse 65, 88397 Biberach/Riss, Germany
| | - Stefan Peters
- Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG , Birkendorfer Strasse 65, 88397 Biberach/Riss, Germany
| | - Nitinchandra D Patel
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Zhulin Tan
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Nathan K Yee
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jinhua J Song
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Frank Roschangar
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Marisa C Kozlowski
- Department of Chemistry, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States
| | - Chris H Senanayake
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| |
Collapse
|
25
|
Friedfeld MR, Shevlin M, Margulieux GW, Campeau LC, Chirik PJ. Cobalt-Catalyzed Enantioselective Hydrogenation of Minimally Functionalized Alkenes: Isotopic Labeling Provides Insight into the Origin of Stereoselectivity and Alkene Insertion Preferences. J Am Chem Soc 2016; 138:3314-24. [DOI: 10.1021/jacs.5b10148] [Citation(s) in RCA: 146] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- Max R. Friedfeld
- Department
of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
| | - Michael Shevlin
- Department of Process & Analytical Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065, United States
| | - Grant W. Margulieux
- Department
of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
| | - Louis-Charles Campeau
- Department of Process & Analytical Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065, United States
| | - Paul J. Chirik
- Department
of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
| |
Collapse
|
26
|
Qu B, Samankumara LP, Ma S, Fandrick KR, Desrosiers JN, Rodriguez S, Li Z, Haddad N, Han ZS, McKellop K, Pennino S, Grinberg N, Gonnella NC, Song JJ, Senanayake CH. A Mild Dihydrobenzooxaphosphole Oxazoline/Iridium Catalytic System for Asymmetric Hydrogenation of Unfunctionalized Dialins. Angew Chem Int Ed Engl 2014. [DOI: 10.1002/ange.201408929] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
27
|
Qu B, Samankumara LP, Ma S, Fandrick KR, Desrosiers JN, Rodriguez S, Li Z, Haddad N, Han ZS, McKellop K, Pennino S, Grinberg N, Gonnella NC, Song JJ, Senanayake CH. A Mild Dihydrobenzooxaphosphole Oxazoline/Iridium Catalytic System for Asymmetric Hydrogenation of Unfunctionalized Dialins. Angew Chem Int Ed Engl 2014; 53:14428-32. [DOI: 10.1002/anie.201408929] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2014] [Indexed: 11/06/2022]
|
28
|
Cormanich RA, Rittner R, O’Hagan D, Bühl M. Analysis of CF···FC Interactions on Cyclohexane and Naphthalene Frameworks. J Phys Chem A 2014; 118:7901-10. [DOI: 10.1021/jp504568c] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Rodrigo A. Cormanich
- School
of Chemistry, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, U.K
- Chemistry
Institute, State University of Campinas, P.O. Box 6154, 13083-971 Campinas, SP, Brazil
| | - Roberto Rittner
- Chemistry
Institute, State University of Campinas, P.O. Box 6154, 13083-971 Campinas, SP, Brazil
| | - David O’Hagan
- School
of Chemistry, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, U.K
| | - Michael Bühl
- School
of Chemistry, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, U.K
| |
Collapse
|
29
|
Qu B, Samankumara LP, Savoie J, Fandrick DR, Haddad N, Wei X, Ma S, Lee H, Rodriguez S, Busacca CA, Yee NK, Song JJ, Senanayake CH. Synthesis of Pyridyl-dihydrobenzooxaphosphole Ligands and Their Application in Asymmetric Hydrogenation of Unfunctionalized Alkenes. J Org Chem 2014; 79:993-1000. [DOI: 10.1021/jo4024864] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Bo Qu
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Lalith P. Samankumara
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jolaine Savoie
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Daniel R. Fandrick
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Nizar Haddad
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xudong Wei
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Shengli Ma
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Heewon Lee
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Sonia Rodriguez
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Carl A. Busacca
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Nathan K. Yee
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jinhua J. Song
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Chris H. Senanayake
- Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| |
Collapse
|
30
|
Busacca CA, Qu B, Farber E, Haddad N, Grět N, Saha AK, Eriksson MC, Wu JP, Fandrick KR, Han S, Grinberg N, Ma S, Lee H, Li Z, Spinelli M, Gold A, Wang G, Wipf P, Senanayake CH. Hydrophosphination of Propargylic Alcohols and Amines with Phosphine Boranes. Org Lett 2013; 15:1132-5. [DOI: 10.1021/ol400309y] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Carl A. Busacca
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Bo Qu
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Elisa Farber
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Nizar Haddad
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Nicole Grět
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Anjan K. Saha
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Magnus C. Eriksson
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Jiang-Ping Wu
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Keith R. Fandrick
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Steve Han
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Nelu Grinberg
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Shengli Ma
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Heewon Lee
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Zhibin Li
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Michael Spinelli
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Austin Gold
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Guijun Wang
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Peter Wipf
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| | - Chris H. Senanayake
- Chemical Development, Boehringer-Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States, Department of Chemistry, Center for Chemical Methodologies and Library Development, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, Pennsylvania 15260, United States, and Department of Chemistry and Biochemistry, Old Dominion University, 4541 Hampton Boulevard, Norfolk, Virginia 23529, United States
| |
Collapse
|